{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:02:14Z","timestamp":1767135734941,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007910","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000}}],"reference-count":83,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007910.pub2","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T15:54:34Z","timestamp":1430754874000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interventions for lowering plasma homocysteine levels in kidney transplant recipients"],"prefix":"10.1002","volume":"2015","author":[{"given":"Amy","family":"Kang","sequence":"first","affiliation":[{"name":"The University of Sydney; Sydney Medical School; Camperdown NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar U","family":"Nigwekar","sequence":"additional","affiliation":[{"name":"Harvard Medical School; Brigham and Women's Hospital, Massachusetts General Hospital, Scholars in Clinical Sciences Program; Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Camperdown NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyarth","family":"Kulshrestha","sequence":"additional","affiliation":[{"name":"University of Iowa Carver College of Medicine; Nephrology; 200 Hawkins Drive-T307GH Iowa City IA USA 52242"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Zoungas","sequence":"additional","affiliation":[{"name":"Monash University; Diabetes and Vascular Research Program, Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine; Clayton VIC Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankar D","family":"Navaneethan","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute, Cleveland Clinic; Department of Nephrology and Hypertension; Cleveland OH USA 44195"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Cass","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research; PO Box 41096 Casuarina NT Australia 0811"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin P","family":"Gallagher","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Renal and Metabolic Division; Camperdown NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Renal and Metabolic Division; Camperdown NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"The Children\u2019s Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead Australia"},{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum Medical Scientific Office; Lund Sweden"},{"name":"Diaverum Academy; Bari Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meg J","family":"Jardine","sequence":"additional","affiliation":[{"name":"The University of Sydney; The George Institute for Global Health; PO Box M201 Missenden Rd Camperdown NSW Australia 2050"},{"name":"Concord Repatriation General Hospital; Department of Renal Medicine; Hospital Road Concord NSW Australia 2139"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD007910.pub2-BIB0001|cit1","first-page":"883A","article-title":"Baseline characteristics of the folic acid for vascular outcome reduction in transplantation (FAVOURIT) trial [abstract no: PUB316]","volume":"19","author":"Bostom","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007910.pub2-BIB0003|cit2","first-page":"429","article-title":"Baseline characteristics of participants in the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial [abstract no: 827]","volume":"9","author":"Bostom","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0002|cit3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2008.08.010","article-title":"Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial","volume":"53","author":"Bostom","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0004|cit4","unstructured":"Bostom AG Carpenter MA Kusek JW Hunsicker LG Jacques P Levey AS Homocysteine-lowering in chronic stable renal transplant recipients: the FAVORIT Trial [abstract no: LB001] American Society of Nephrology Renal Week; 2009 Oct 27-Nov 1; San Diego, CA 2009"},{"issue":"3","key":"10.1002\/14651858.CD007910.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.ahj.2006.03.004","article-title":"Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial","volume":"152","author":"Bostom","year":"2006","journal-title":"American Heart Journal"},{"issue":"16","key":"10.1002\/14651858.CD007910.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007910.pub2-BIB0007|cit7","first-page":"375","article-title":"Higher systolic blood pressure is associated with increased cardiovascular risk in patients with hypertension in the Folic Acid for Vascular Outcome Reduction in Transplantation trial [abstract]","volume":"11","author":"Carpenter","year":"2011","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0008|cit8","first-page":"888A","article-title":"Untreated CVD risk factors in chronic, stable kidney transplant recipients at baseline in the folic acid for vascular outcome reduction (FAVORIT) study [abstract no: PUB271]","volume":"20","author":"Carpenter","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD007910.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007910.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"E438","DOI":"10.1111\/j.1399-0012.2012.01676.x","article-title":"Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study","volume":"26","author":"Carpenter","year":"2012","journal-title":"Clinical Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007910.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.jrn.2011.07.009","article-title":"Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT)","volume":"22","author":"Troen","year":"2012","journal-title":"Journal of Renal Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD007910.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","article-title":"Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial","volume":"12","author":"Weiner","year":"2012","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0013|cit13","first-page":"e-pub ahead of","article-title":"Safety events in kidney transplant recipients: Results from the Folic Acid for Vascular Outcome Reduction in Transplant Trial","author":"Weir","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007910.pub2-BIB0014|cit14","first-page":"509","article-title":"Hyperhomocysteinemia and its therapy in renal transplant recipients with combination of vit B6, vit B12 and folic acid [abstract]","volume":"18","author":"Ardalan","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Austen SK Fassett RG Geraghty DP Coombes JS Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients Clinical Nephrology 2006 373 9 17140167","DOI":"10.5414\/CNP66373"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Beaulieu AJ Gohh RY Han H Hakas D Jacques PF Selhub J Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients Arteriosclerosis, Thrombosis & Vascular Biology 1999 2918 21 10591669","DOI":"10.1161\/01.ATV.19.12.2918"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007910.pub2-BIB0017|cit17","first-page":"730A","article-title":"Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients (RTR) [abstract]","volume":"10","author":"Gohh","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0018|cit18","unstructured":"Biagini M Bertoni E Marcucci R Zanazzi M Rosati A Fedi S Vitamin supplementation reduces the progression atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami, FL 2002"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007910.pub2-BIB0019|cit19","first-page":"675A","article-title":"Homocysteine-lowering treatment of renal transplant recipients [abstract]","volume":"8","author":"Bostom","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Bostom AG Gohh RY Beaulieu AJ Nadeau MR Hume AL Jacques PF Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial Annals of Internal Medicine 1997 1089 92 9412311","DOI":"10.7326\/0003-4819-127-12-199712150-00006"},{"issue":"24","key":"10.1002\/14651858.CD007910.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.101.24.2829","article-title":"Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. [erratum appears in Circulation 2000 Aug 1;102(5):598]","volume":"101","author":"Bostom","year":"2000","journal-title":"Circulation"},{"issue":"Sept","key":"10.1002\/14651858.CD007910.pub2-BIB0022|cit22","first-page":"257A","article-title":"Reduced folates are an expensive treatment for hyperhomocysteinemia in hemodialysis patients with no greater efficacy than folic acid: results of a controlled comparison study [abstract]","volume":"11","author":"Bostom","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"78","key":"10.1002\/14651858.CD007910.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1046\/j.1523-1755.2001.59780246.x","article-title":"Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients","volume":"59","author":"Bostom","year":"2001","journal-title":"Kidney International - Supplement"},{"issue":"10","key":"10.1002\/14651858.CD007910.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/00007890-200005270-00029","article-title":"Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients","volume":"69","author":"Bostom","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/ndt\/gfg1028","article-title":"Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation","volume":"18 Suppl 1","author":"Jurewicz","year":"2003 May","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.transproceed.2005.12.077","article-title":"Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation","volume":"38","author":"Juskowa","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007910.pub2-BIB0027|cit27","first-page":"A134","article-title":"The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients [abstract no: 132]","volume":"13","author":"Kaisar","year":"2008","journal-title":"Nephrology"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2369-10-29","article-title":"Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study","volume":"10","author":"Kaisar","year":"2009","journal-title":"BMC Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0041-1345(97)01227-X","article-title":"The effect of garlic on hypercholesterolemia in renal transplant patients","volume":"30","author":"Lash","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD007910.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1016\/j.transproceed.2005.08.063","article-title":"Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation","volume":"37","author":"Manrique","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD007910.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2007.02506.x","article-title":"Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients","volume":"5","author":"Manrique","year":"2007","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007910.pub2-BIB0032|cit32","first-page":"74P","article-title":"Vitamin supplement reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract no: F-FC055]","volume":"13","author":"Bertoni","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD007910.pub2-BIB0033|cit33","first-page":"31","article-title":"Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract]","volume":"17","author":"Marcucci","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007910.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.transproceed.2005.06.101","article-title":"Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients","volume":"37","author":"Marcucci","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD007910.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/01.TP.0000058810.59825.58","article-title":"Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients","volume":"75","author":"Marcucci","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007910.pub2-BIB0036|cit36","first-page":"510","article-title":"Vitamin supplement reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients [abstract]","volume":"18","author":"Rosati","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0037|cit37","first-page":"33","article-title":"Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial","volume":"7","author":"Nafar","year":"2009","journal-title":"Experimental & Clinical Transplantation"},{"issue":"Oct","key":"10.1002\/14651858.CD007910.pub2-BIB0038|cit38","first-page":"747A","article-title":"Vitamin supplements improve the lipid profile in renal transplant patients: a randomized clinical trial [abstract no: SU-PO994]","volume":"15","author":"Perez","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007910.pub2-BIB0039|cit39","first-page":"5","article-title":"Intravenous administration of N-acetylcysteine reduces plasma total homocysteine levels in renal transplant recipients","volume":"14","author":"Rymarz","year":"2009","journal-title":"Annals of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007910.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0041-1345(02)03160-3","article-title":"Effect of folic acid therapy on serum homocysteine level in renal transplant recipients","volume":"34","author":"Savaj","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD007910.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1053\/ajkd.2001.27412","article-title":"Treatment of hyperhomocysteinemia in end-stage renal disease","volume":"38","author":"Shemin","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007910.pub2-BIB0042|cit42","first-page":"509","article-title":"Effective treatment of hyperhomocysteinemia and obesity reduces the risk after renal transplantation [abstract no: T711]","volume":"18","author":"Teplan","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0043|cit43","unstructured":"Xu T Wang XF Qu XK Ye HY Huang XB Zhang XP Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 2005 940 3 16083628"},{"issue":"3","key":"10.1002\/14651858.CD007910.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.juro.2007.10.028","article-title":"Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population","volume":"179","author":"Xu","year":"2008","journal-title":"Journal of Urology"},{"issue":"17","key":"10.1002\/14651858.CD007910.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"9374","key":"10.1002\/14651858.CD007910.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"issue":"15","key":"10.1002\/14651858.CD007910.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0048|cit48","unstructured":"CARI Care for kidney transplant recipients. 2012 www.cari.org.au\/Transplantation\/transplantation%20care%20of%20recipients\/transplant_care_of_recipients.html"},{"issue":"18","key":"10.1002\/14651858.CD007910.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007910.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu3030370","article-title":"Folic acid food fortification-its history, effect, concerns, and future directions","volume":"3","author":"Crider","year":"2011","journal-title":"Nutrients"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V111134","article-title":"Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study","volume":"11","author":"Ducloux","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0053|cit53","first-page":"28","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.5. Cardiovascular risks. Hyperhomocysteinaemia","volume":"17 Suppl 4","author":"EBPG Expert Group on Renal Transplantation","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7109","key":"10.1002\/14651858.CD007910.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD007910.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/TP.0b013e3181a76823","article-title":"Cyclosporine withdrawal improves long-term graft survival in renal transplantation","volume":"87","author":"Gallagher","year":"2009","journal-title":"Transplantation"},{"issue":"7414","key":"10.1002\/14651858.CD007910.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0057|cit57","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"16","key":"10.1002\/14651858.CD007910.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","journal-title":"JAMA"},{"issue":"7606","key":"10.1002\/14651858.CD007910.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/bmj.39232.496227.47","article-title":"Should folic acid fortification be mandatory? No","volume":"334","author":"Hubner","year":"2007","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD007910.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"e3533","DOI":"10.1136\/bmj.e3533","article-title":"The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis","volume":"344","author":"Jardine","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0063|cit63","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9 Suppl 3","author":"Kidney Disease: Improving Global Outcomes (KDIGO)Transplant Work Group","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007910.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.ATV.20.2.422","article-title":"Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions","volume":"20","author":"Lang","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, & Vascular Biology"},{"issue":"6","key":"10.1002\/14651858.CD007910.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI115514","article-title":"Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine","volume":"88","author":"Lentz","year":"1991","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI118771","article-title":"Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia","volume":"98","author":"Lentz","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"15","key":"10.1002\/14651858.CD007910.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007910.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ndt\/9.8.1103","article-title":"Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients","volume":"9","author":"Massy","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007910.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0070|cit70","unstructured":"National Institutes of Health U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2007 www.usrds.org\/atlas07.aspx"},{"issue":"9","key":"10.1002\/14651858.CD007910.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/bdra.20830","article-title":"Effects of folic acid fortification on spina bifida prevalence In Brazil","volume":"91","author":"Orioli","year":"2011","journal-title":"Birth Defects Research"},{"issue":"8","key":"10.1002\/14651858.CD007910.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD007910.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD007910.pub2-BIB0074|cit74","unstructured":"Holt S Goldsmith D Cardiovascular disease in CKD. 2010 www.renal.org\/guidelines\/modules\/cardiovascular-disease-in-ckd#Summary2"},{"issue":"5","key":"10.1002\/14651858.CD007910.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007910.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodialysis International"},{"issue":"9871","key":"10.1002\/14651858.CD007910.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(12)62001-7","article-title":"Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals","volume":"381","author":"Vollset","year":"2013","journal-title":"Lancet"},{"issue":"7374","key":"10.1002\/14651858.CD007910.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007910.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1681\/ASN.2004070576","article-title":"Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study","volume":"16","author":"Winkelmayer","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007910.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2-3","key":"10.1002\/14651858.CD007910.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024497419821","article-title":"Classical homocystinuria: vascular risk and its prevention","volume":"26","author":"Yap","year":"2003","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"6","key":"10.1002\/14651858.CD007910.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD007910.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007910","article-title":"Interventions for lowering plasma homocysteine levels in kidney transplant recipients","author":"Kang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007910.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:32:33Z","timestamp":1705293153000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007910.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007910.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]}}}